Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

LeonaBio, Inc. (LONA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

LeonaBio, Inc. (LONA), most recent 12 months reported: net loss $141.46M. Latest balance sheet on file: liquid cash $51.07M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): KALARIS THERAPEUTICS, INC. · Kodiak Sciences Inc. · Kyverna Therapeutics, Inc. · LIMINATUS PHARMA, INC. · Lexeo Therapeutics, Inc. · MAZE THERAPEUTICS, INC. · NEUMORA THERAPEUTICS, INC. · OUTLOOK THERAPEUTICS, INC.

Stock screener

Watchlist